VCPE Conference 2022 Conference Book

VCPE CONFERENCE 2022 1
WELCOME
Distinguished Guests:
Thank you for joining us at the 28th annual Venture Capital Private Equity Conference at Harvard Business School.
We are honored to help carry on the tradition of thought leadership and innovation that the conference embodies.
While the conference has started from humble origins, it is today one of the largest and most anticipated stu-
dent-run conferences in the country, with industry professionals, students, alumni, and faculty coming together to
discuss the most pressing issues facing the alternative investing industry.
The conference team is thrilled to provide a platform for professionals and students to hear from and interact with
some of the industry’s most revered leaders. From the student perspective, we believe these interactions will equip
all of us with the tools to succeed as we are about to embark on our own careers.
As in prior years, the conference will feature a wide array of keynote speeches and panel discussions. This year’s
conference, while continuing long-running favorite panels such as State of Private Equity and State of Venture
Capital, has also identified new industry trends and shaped the agenda accordingly. Our Portfolio Operations and
Climate panels cover topics of ever-increasing importance in the alternative investing industry today, while Invest-
ing in Inclusive Economies, EdTech and the Future of Work, India, and LatAm are getting at the essence of what’s
shaping the world tomorrow.
The team has strived to embody diversity not as a separate topic, but throughout our representation in panels and
keynote speakers. We view diversity holistically, including both gender, race, and sexual orientation, as well as
background and geography. We believe that this emphasis further enriches the conference experience and invites
conversation on how the industry can advance equity.
After a prolonged pause to in person events due to the pandemic, we would like to give a warm thank you to our
speakers for venturing out to a chilly Boston in February. We are immensely grateful for their enthusiasm and
generosity. Their willingness to join us and to help brainstorm the most relevant discussion topics has touched us
deeply, and has given us a vivid example of what true leadership looks like.
We would be remiss if we did not call out the hard work and dedication of our conference team. Having worked on
the conference for a second year in a row, we are proud of the passion, enthusiasm and drive that has permeated
the team this year.
WELCOME
Distinguished Guests:
Thank you for joining us at the 28th annual Venture Capital Private Equity Conference at Harvard Business School.
We are honored to help carry on the tradition of thought leadership and innovation that the conference embodies.
While the conference has started from humble origins, it is today one of the largest and most anticipated stu-
dent-run conferences in the country, with industry professionals, students, alumni, and faculty coming together to
discuss the most pressing issues facing the alternative investing industry.
The conference team is thrilled to provide a platform for professionals and students to hear from and interact with
some of the industry’s most revered leaders. From the student perspective, we believe these interactions will equip
all of us with the tools to succeed as we are about to embark on our own careers.
As in prior years, the conference will feature a wide array of keynote speeches and panel discussions. This year’s
conference, while continuing long-running favorite panels such as State of Private Equity and State of Venture
Capital, has also identified new industry trends and shaped the agenda accordingly. Our Portfolio Operations and
Climate panels cover topics of ever-increasing importance in the alternative investing industry today, while Invest-
ing in Inclusive Economies, EdTech and the Future of Work, India, and LatAm are getting at the essence of what’s
shaping the world tomorrow.
The team has strived to embody diversity not as a separate topic, but throughout our representation in panels and
keynote speakers. We view diversity holistically, including both gender, race, and sexual orientation, as well as
background and geography. We believe that this emphasis further enriches the conference experience and invites
conversation on how the industry can advance equity.
After a prolonged pause to in person events due to the pandemic, we would like to give a warm thank you to our
speakers for venturing out to a chilly Boston in February. We are immensely grateful for their enthusiasm and
generosity. Their willingness to join us and to help brainstorm the most relevant discussion topics has touched us
deeply, and has given us a vivid example of what true leadership looks like.
We would be remiss if we did not call out the hard work and dedication of our conference team. Having worked on
the conference for a second year in a row, we are proud of the passion, enthusiasm and drive that has permeated
the team this year.

VCPE CONFERENCE 2022 VCPE CONFERENCE 2022
2
We are also appreciative of the continued, generous support of our sponsors, without whom the conference would
not have been possible. Their substantial networks and experience are integral to making this weekend valuable
for all participants.
A special thank you to the Harvard Business School faculty and administration for their support and dedication for
this event. We’ would like to especially recognize John Dionne, one of Harvard Business School’s most beloved and
esteemed faculty, who was there with us from the very beginning, selflessly dedicating his personal time to offer
us guidance and advice.
On behalf of our team, thank you for joining us, and we hope you enjoy the conference!
Jakob Blomqvist and Camelia Popescu
Co-Presidents of the VCPE Conference
VCPE CONFERENCE 2022
2
We are also appreciative of the continued, generous support of our sponsors, without whom the conference would
not have been possible. Their substantial networks and experience are integral to making this weekend valuable
for all participants.
A special thank you to the Harvard Business School faculty and administration for their support and dedication for
this event. We’ would like to especially recognize John Dionne, one of Harvard Business School’s most beloved and
esteemed faculty, who was there with us from the very beginning, selflessly dedicating his personal time to offer
us guidance and advice.
On behalf of our team, thank you for joining us, and we hope you enjoy the conference!
Jakob Blomqvist and Camelia Popescu
Co-Presidents of the VCPE Conference

AGENDA
8:00 – 8:45am Check-In & Breakfast
8:55 – 9:00am Welcome from the VCPE Conference Co-Presidents | MAIN STAGE
9:00 – 9:50am Keynote: David Roux, Moderated by Professor Josh Lerner | MAIN STAGE
10:00 – 10:50am Panel Group 1
State of VC | MAIN STAGE
India | ENSEMBLE E
Life Sciences & Biotech | ENSEMBLE F
Managing a Career in Investing | ENSEMBLE G
State of PE | MAIN STAGE
LatAm | ENSEMBLE E
Seed Funds | ENSEMBLE F
Investing in Inclusive Economies | ENSEMBLE G
12:00 – 12:50pm Keynote: Meg Whitman, Moderated by Kristin W. Mugford | MAIN STAGE
1:00 – 1:50pm Lunch
2:00 – 2:50pm Panel Group 3
Technology | MAIN STAGE
EdTech and Future of Work | ENSEMBLE E
Launching Your First Fund | ENSEMBLE F
Portfolio Operations | ENSEMBLE G
Healthcare | MAIN STAGE
Climate | ENSEMBLE F
Special Situations and Credit Opportunities | ENSEMBLE E
B2B SaaS | ENSEMBLE G
Growth Equity | MAIN STAGE
Family Offices | ENSEMBLE F
Consumer | ENSEMBLE G
5:00 – 6:00pm Keynote: Yup S. Kim, Moderated by John Dionne | MAIN STAGE
Harvard COOP 20% off online items for VCPE Conference guests
with code HBSVCPE*.
Online only, excludes textbooks, regalia, and rings. Cannot be combined with other discounts and/or promotions.
Does not apply to tax or shipping/
Conference is off the record. No video recording.
Coffee, water, and snacks are offered throughout the day.
VCPE CONFERENCE 2022 VCPE CONFERENCE 2022 3
AGENDA
8:00 – 8:45am Check-In & Breakfast
8:55 – 9:00am Welcome from the VCPE Conference Co-Presidents | MAIN STAGE
9:00 – 9:50am Keynote: David Roux, Moderated by Professor Josh Lerner | MAIN STAGE
State of VC | MAIN STAGE
India | ENSEMBLE E
Life Sciences & Biotech | ENSEMBLE F
Managing a Career in Investing | ENSEMBLE G
State of PE | MAIN STAGE
LatAm | ENSEMBLE E
Seed Funds | ENSEMBLE F
Investing in Inclusive Economies | ENSEMBLE G
12:00 – 12:50pm Keynote: Meg Whitman, Moderated by Kristin W. Mugford | MAIN STAGE
1:00 – 1:50pm Lunch
Technology | MAIN STAGE
EdTech and Future of Work | ENSEMBLE E
Launching Your First Fund | ENSEMBLE F
Portfolio Operations | ENSEMBLE G
Healthcare | MAIN STAGE
Climate | ENSEMBLE F
Special Situations and Credit Opportunities | ENSEMBLE E
B2B SaaS | ENSEMBLE G
Growth Equity | MAIN STAGE
Family Offices | ENSEMBLE F
Consumer | ENSEMBLE G
5:00 – 6:00pm Keynote: Yup S. Kim, Moderated by John Dionne | MAIN STAGE
Harvard COOP 20% off online items for VCPE Conference guests
with code HBSVCPE*.
Online only, excludes textbooks, regalia, and rings. Cannot be combined with other discounts and/or promotions.
Does not apply to tax or shipping/
Conference is off the record. No video recording.
Coffee, water, and snacks are offered throughout the day.

KEYNOTE SPEAKERS
THANK YOU TO OUR SPONSORS
PLATINUM SPONSORS
SAPPHIRE SPONSORS
GOLD SPONSORS
SILVER SPONSORS
THANK YOU TO OUR SPONSORS
PLATINUM SPONSORS
SAPPHIRE SPONSORS
GOLD SPONSORS
SILVER SPONSORS

KEYNOTE SPEAKERS KEYNOTE SPEAKERS

6
KEYNOTE: DAVID ROUX
9:00 – 9:50am | Main Stage
David Roux
Co-Founder and Co-Managing Partner, BayPine Capital;
Co-Founder, Silver Lake Partners
David is the co-founder and co-managing partner of BayPine Capital. He previously co-found-
ed Silver Lake Partners in 1999 and held various leadership positions there, including Chair-
man, co-managing partner, and co-CEO.
David is also Chairman of Jackson Laboratories, an independent biomedical research insti-
tute, and recently founded The Roux Institute at Northeastern University, a graduate school
focused on digital engineering, computational biology and the practical application of artificial
intelligence. He also serves on the boards of Boston Scientific, Bristol Seafoods, and The
Institute for Health Metrics and Evaluation at Washington University.
Earlier in his career David worked as a senior executive at Oracle, Liberate, Lotus and Datext.
He grew up in Maine and attended Harvard College (A.B., 1978), Kings College at Cambridge
University (M.Phil., 1980) and Harvard Business School (MBA, 1984). David resides in Boca
Grande, Florida and Upperville, Virginia. He is married to Barbara Roux, and they have three
grown children.
Josh Lerner [MODERATOR]
Jacob H. Schiff Professor of Investment Banking,
Harvard Business School
Josh Lerner graduated from Yale College with a special divisional major. He worked for several
years on issues concerning technological innovation and public policy at the Brookings Insti-
tution, for a public-private task force in Chicago, and on Capitol Hill. He then earned a Ph.D.
from Harvard’s Economics Department.
6
KEYNOTE: DAVID ROUX
9:00 – 9:50am | Main Stage
David Roux
Co-Founder and Co-Managing Partner, BayPine Capital;
Co-Founder, Silver Lake Partners
David is the co-founder and co-managing partner of BayPine Capital. He previously co-found-
ed Silver Lake Partners in 1999 and held various leadership positions there, including Chair-
man, co-managing partner, and co-CEO.
David is also Chairman of Jackson Laboratories, an independent biomedical research insti-
tute, and recently founded The Roux Institute at Northeastern University, a graduate school
focused on digital engineering, computational biology and the practical application of artificial
intelligence. He also serves on the boards of Boston Scientific, Bristol Seafoods, and The
Institute for Health Metrics and Evaluation at Washington University.
Earlier in his career David worked as a senior executive at Oracle, Liberate, Lotus and Datext.
He grew up in Maine and attended Harvard College (A.B., 1978), Kings College at Cambridge
University (M.Phil., 1980) and Harvard Business School (MBA, 1984). David resides in Boca
Grande, Florida and Upperville, Virginia. He is married to Barbara Roux, and they have three
grown children.
Josh Lerner [MODERATOR]
Jacob H. Schiff Professor of Investment Banking,
Josh Lerner graduated from Yale College with a special divisional major. He worked for several
years on issues concerning technological innovation and public policy at the Brookings Insti-
tution, for a public-private task force in Chicago, and on Capitol Hill. He then earned a Ph.D.
from Harvard’s Economics Department.

| 9:00 – 9:50am | Main Stage
Much of his research focuses on venture capital and private equity organizations. (This re-
search is summarized in Boulevard of Broken Dreams, The Money of Invention, Patent Capital,
and The Venture Capital Cycle.) He also examines policies on innovation and how they impact
firm strategies. (That research is discussed in the books The Architecture of Innovation, The
Comingled Code, and Innovation and Its Discontents.) He co-directs the National Bureau of
Economic Research’s Productivity, Innovation, and Entrepreneurship Program and serves as
co-editor of their publication, Innovation Policy and the Economy. He founded and runs the
Private Capital Research Institute, a nonprofit devoted to encouraging access to data and
research, and has been a frequent leader of and participant in the World Economic Forum
projects and events.
| 9:00 – 9:50am | Main Stage
Much of his research focuses on venture capital and private equity organizations. (This re-
search is summarized in Boulevard of Broken Dreams, The Money of Invention, Patent Capital,
and The Venture Capital Cycle.) He also examines policies on innovation and how they impact
firm strategies. (That research is discussed in the books The Architecture of Innovation, The
Comingled Code, and Innovation and Its Discontents.) He co-directs the National Bureau of
Economic Research’s Productivity, Innovation, and Entrepreneurship Program and serves as
co-editor of their publication, Innovation Policy and the Economy. He founded and runs the
Private Capital Research Institute, a nonprofit devoted to encouraging access to data and
research, and has been a frequent leader of and participant in the World Economic Forum
projects and events.

8
KEYNOTE: MEG WHITMAN
12:00 – 12:50pm | Main Stage
Meg Whitman
Former President & CEO, Hewlett Packard Enterprises;
Former President & CEO, eBay; Former CEO, Quibi
Until recently, Meg Whitman was the CEO of Quibi, a mobile only media technology platform.
Prior to Quibi, she served as CEO of Hewlett Packard Enterprise and President and CEO for
the Hewlett-Packard Company. Before HP, Meg ran for Governor of California in 2010. Prior to
that, she was President and CEO of eBay Inc. where she oversaw its growth from 30 employ-
ees and $4 million in annual revenue to more than 15,000 employees and $8 billion in annual
revenue. She has also held executive-level positions at Procter and Gamble Company, Hasbro
Inc., The Walt Disney Company, and Bain & Company. Meg is also the national board chair of
Teach for America.
On December 8, 2021, President Biden announced his intent to nominate Meg Whitman for
U.S. ambassador to the Republic of Kenya.
Meg received her B.A. from Princeton University and MBA from Harvard Business School.
Kristin W. Mugford [MODERATOR]
Melvin Tukman Senior Lecturer of Business Administration,
Kristin Mugford is the Melvin Tukman Senior Lecturer of Business Administration in the Fi-
nance Unit at the Harvard Business School. In 2013 Kristin retired from her position as Man-
aging Director of Bain Capital, one of the world’s leading private investment firms. Bain Capital
and its affiliated advisors make private equity, public equity, fixed income and credit, venture
capital, and absolute return investments across multiple geographies and industries.
Kristin joined Bain Capital’s private equity business in 1994 and at the age of 32, became the
first female Managing Director in the firm’s history. Kristin helped start Bain Capital Credit
8
KEYNOTE: MEG WHITMAN
12:00 – 12:50pm | Main Stage
Meg Whitman
Former President & CEO, Hewlett Packard Enterprises;
Former President & CEO, eBay; Former CEO, Quibi
Until recently, Meg Whitman was the CEO of Quibi, a mobile only media technology platform.
Prior to Quibi, she served as CEO of Hewlett Packard Enterprise and President and CEO for
the Hewlett-Packard Company. Before HP, Meg ran for Governor of California in 2010. Prior to
that, she was President and CEO of eBay Inc. where she oversaw its growth from 30 employ-
ees and $4 million in annual revenue to more than 15,000 employees and $8 billion in annual
revenue. She has also held executive-level positions at Procter and Gamble Company, Hasbro
Inc., The Walt Disney Company, and Bain & Company. Meg is also the national board chair of
Teach for America.
On December 8, 2021, President Biden announced his intent to nominate Meg Whitman for
U.S. ambassador to the Republic of Kenya.
Meg received her B.A. from Princeton University and MBA from Harvard Business School.
Kristin W. Mugford [MODERATOR]
Melvin Tukman Senior Lecturer of Business Administration,
Kristin Mugford is the Melvin Tukman Senior Lecturer of Business Administration in the Fi-
nance Unit at the Harvard Business School. In 2013 Kristin retired from her position as Man-
aging Director of Bain Capital, one of the world’s leading private investment firms. Bain Capital
and its affiliated advisors make private equity, public equity, fixed income and credit, venture
capital, and absolute return investments across multiple geographies and industries.
Kristin joined Bain Capital’s private equity business in 1994 and at the age of 32, became the
first female Managing Director in the firm’s history. Kristin helped start Bain Capital Credit

| 12:00 – 12:50pm | Main Stage
(founded as Sankaty Advisors), and prior to her retirement was responsible for the oversight of
their high yield investments and a senior member of Bain Capital Credit’s management team
and investment committee. Bain Capital Credit is one of the leading corporate and distressed
debt managers, managing over $40 billion in offices around the world.
Kristin began her career at the Walt Disney Company, where she worked in corporate strategic
planning and the consumer products division. She graduated from Harvard Business School
as a Baker Scholar and holds an A.B. with honors from Harvard College.
| 12:00 – 12:50pm | Main Stage
(founded as Sankaty Advisors), and prior to her retirement was responsible for the oversight of
their high yield investments and a senior member of Bain Capital Credit’s management team
and investment committee. Bain Capital Credit is one of the leading corporate and distressed
debt managers, managing over $40 billion in offices around the world.
Kristin began her career at the Walt Disney Company, where she worked in corporate strategic
planning and the consumer products division. She graduated from Harvard Business School
as a Baker Scholar and holds an A.B. with honors from Harvard College.

10
KEYNOTE: YUP S. KIM
5:00 – 5:50pm | Main Stage
Yup S. Kim
Head of Investments for Private Equity
and Investment Director, CalPERS
Mr. Yup S. Kim serves as the Head of Investments for Private Equity and Investment Director
at CalPERS, California’s $500 billion pension fund. He serves on the private equity invest-
ment review committee and helps lead CalPERS’ private equity program across all functions,
including strategy, team management, and investment activities across primary, secondary,
and co-investment opportunities globally.
Previously, he served as the Senior Portfolio Manager at the Alaska Permanent Fund Corpo-
ration (“APFC”), a $80 billion sovereign wealth fund, where he helped lead their private invest-
ment activities. The private equity and special opportunities portfolio generated 25% net of
fee returns over the past decade.
He also held positions at DB Private Equity, where he served on the investment committee,
Performance Equity, Silver Point Capital and began his career at Citigroup in New York.
Yup received his B.A. in Economics from Yale University and speaks six languages.
John Dionne [MODERATOR]
Senior Lecturer of Business Administration, Harvard Business School
John D. Dionne is a Senior Advisor to Blackstone and a Senior Lecturer of Business Adminis-
tration in the Finance Unit at the Harvard Business School.
Until he retired from his position as a Senior Managing Director of Blackstone in 2013, John
was most recently its Global Head of the Private Equity Business Development and Investor
Relations Groups and served as a member of its Global Private Equity Investment and Valua-
tion Committees. During his tenure in this position, Mr. Dionne led global fundraising efforts of
10
KEYNOTE: YUP S. KIM
5:00 – 5:50pm | Main Stage
Yup S. Kim
Head of Investments for Private Equity
and Investment Director, CalPERS
Mr. Yup S. Kim serves as the Head of Investments for Private Equity and Investment Director
at CalPERS, California’s $500 billion pension fund. He serves on the private equity invest-
ment review committee and helps lead CalPERS’ private equity program across all functions,
including strategy, team management, and investment activities across primary, secondary,
and co-investment opportunities globally.
Previously, he served as the Senior Portfolio Manager at the Alaska Permanent Fund Corpo-
ration (“APFC”), a $80 billion sovereign wealth fund, where he helped lead their private invest-
ment activities. The private equity and special opportunities portfolio generated 25% net of
fee returns over the past decade.
He also held positions at DB Private Equity, where he served on the investment committee,
Performance Equity, Silver Point Capital and began his career at Citigroup in New York.
Yup received his B.A. in Economics from Yale University and speaks six languages.
John Dionne [MODERATOR]
John D. Dionne is a Senior Advisor to Blackstone and a Senior Lecturer of Business Adminis-
tration in the Finance Unit at the Harvard Business School.
Until he retired from his position as a Senior Managing Director of Blackstone in 2013, John
was most recently its Global Head of the Private Equity Business Development and Investor
Relations Groups and served as a member of its Global Private Equity Investment and Valua-
tion Committees. During his tenure in this position, Mr. Dionne led global fundraising efforts of

| 5:00 – 5:50pm | Main Stage
over $30 billion immediately following the financial crisis. He was a co-founder of Blackstone’s
Tactical Opportunities, Energy, and Distressed Securities funds.
Before joining Blackstone, Mr. Dionne was a Partner and Portfolio Manager for Bennett Re-
structuring Funds for several years. He co-founded and invested in two multi-billion-dollar
hedge funds specializing in financially troubled companies. He also served on several official
and ad-hoc creditor committees during that time. Previously, Mr. Dionne was a Partner at
Saugatuck Capital, where he invested in middle-market buyouts and restructured troubled
portfolio companies. From 1991 through 1996, he was Director of Corporate Development for
a predecessor of Thermo Fisher Scientific Inc. John began his career at Price Waterhouse as
a public accountant.
John received academic honors while earning an MBA from the Harvard Business School and
was a magna cum laude graduate from the University of Scranton, a past Chair of its Board
of Trustees.
| 5:00 – 5:50pm | Main Stage
over $30 billion immediately following the financial crisis. He was a co-founder of Blackstone’s
Tactical Opportunities, Energy, and Distressed Securities funds.
Before joining Blackstone, Mr. Dionne was a Partner and Portfolio Manager for Bennett Re-
structuring Funds for several years. He co-founded and invested in two multi-billion-dollar
hedge funds specializing in financially troubled companies. He also served on several official
and ad-hoc creditor committees during that time. Previously, Mr. Dionne was a Partner at
Saugatuck Capital, where he invested in middle-market buyouts and restructured troubled
portfolio companies. From 1991 through 1996, he was Director of Corporate Development for
a predecessor of Thermo Fisher Scientific Inc. John began his career at Price Waterhouse as
a public accountant.
John received academic honors while earning an MBA from the Harvard Business School and
was a magna cum laude graduate from the University of Scranton, a past Chair of its Board
of Trustees.

NOTES
12
PANEL GROUP 1 | 10:00 – 10:50AM
STATE OF VC
INDIA
LIFE SCIENCES & BIOTECH
MANAGING A CAREER IN INVESTING
NOTES
12

PANEL GROUP 1 | 10:00 – 10:50AM
STATE OF VC
INDIA
PANEL GROUP 1 | 10:00 – 10:50AM
STATE OF VC
INDIA

14
The State of Venture Capital | 10:00 – 10:50am | Main Stage
14
THE STATE OF VENTURE CAPITAL
10:00 – 10:50am | Main Stage
Venture capital has exploded in the past decade, with the recent pandemic fueling
increased investment in early stage companies. 2021 was a year of outsized early stage
investments, an increase in follow-on funding, and a year of unicorns. In 2021, more
unicorns were created than in the past five years combined. Panelists will discuss their
approachtonavigatingtheimpactofthepandemic,theirfund’svisioninapost-pandemic
world, and how they create partnerships with their portfolio companies to driving value
creation, and build towards a better future.
PANEL CAPTAINS: Daniel Applewhite and Sheila Xu
14
14
THE STATE OF VENTURE CAPITAL
10:00 – 10:50am | Main Stage
Venture capital has exploded in the past decade, with the recent pandemic fueling
increased investment in early stage companies. 2021 was a year of outsized early stage
investments, an increase in follow-on funding, and a year of unicorns. In 2021, more
unicorns were created than in the past five years combined. Panelists will discuss their
approachtonavigatingtheimpactofthepandemic,theirfund’svisioninapost-pandemic
world, and how they create partnerships with their portfolio companies to driving value
creation, and build towards a better future.
PANEL CAPTAINS: Daniel Applewhite and Sheila Xu

Molly Fowler [MODERATOR]
General Partner, Dorm Room Fund
Molly Fowler is the GP of Dorm Room Fund, the nation’s original student venture fund. She
is proud to work alongside the DRF teams to back the strongest student founders at their
earliest stages. Since its founding, DRF has helped 350+ undergrad, MBA, and PhD founders
grow their companies and raise billions of follow-on capital from some of the biggest names
in venture. Before joining DRF, Molly was on the investing team at First Round Capital; an
operator at a Sidewalk Labs/Alphabet-backed tech co; and served in government. She cut her
professional teeth on political campaigns in California. When not hanging with DRF, Molly is
the front woman of a country band and an occasional intern at her local wine shop.
Zav Dar
Partner, Lux Capital
Zavain is driven by smart software, leveraging data and machine intelligence to scale, aug-
ment, and balance human intelligence. He invests in companies that are using machine learn-
ing and AI to augment or replace physical-world functions including biology, language, manu-
facturing and analysis. He looks for entrepreneurs that can use software and data to hone a
philosophical position on where the world is, and how to direct it for the better.
Brian Devaney
Investor, Underscore Ventures
Brian is a Principal at Underscore VC in Boston where he focuses on seed-stage investing in
B2B software. Brian joined Underscore from First Round Capital in San Francisco, early inves-
tors in Uber, Roblox, Square, Warby Parker and Looker. Prior to First Round, Brian was hired
by the founders of Strava to lead go-to-market for a new line of business. Earlier in his career,
Brian was an analyst at a EverBank and a B2B marketing consultant at a leading Hubspot part-
ner agency. Brian earned his B.A. from the University of Vermont where he studied Economics,
Business Administration, and Computer Science.
Molly Fowler [MODERATOR]
General Partner, Dorm Room Fund
Molly Fowler is the GP of Dorm Room Fund, the nation’s original student venture fund. She
is proud to work alongside the DRF teams to back the strongest student founders at their
earliest stages. Since its founding, DRF has helped 350+ undergrad, MBA, and PhD founders
grow their companies and raise billions of follow-on capital from some of the biggest names
in venture. Before joining DRF, Molly was on the investing team at First Round Capital; an
operator at a Sidewalk Labs/Alphabet-backed tech co; and served in government. She cut her
professional teeth on political campaigns in California. When not hanging with DRF, Molly is
the front woman of a country band and an occasional intern at her local wine shop.
Zav Dar
Partner, Lux Capital
Zavain is driven by smart software, leveraging data and machine intelligence to scale, aug-
ment, and balance human intelligence. He invests in companies that are using machine learn-
ing and AI to augment or replace physical-world functions including biology, language, manu-
facturing and analysis. He looks for entrepreneurs that can use software and data to hone a
philosophical position on where the world is, and how to direct it for the better.
Brian Devaney
Investor, Underscore Ventures
Brian is a Principal at Underscore VC in Boston where he focuses on seed-stage investing in
B2B software. Brian joined Underscore from First Round Capital in San Francisco, early inves-
tors in Uber, Roblox, Square, Warby Parker and Looker. Prior to First Round, Brian was hired
by the founders of Strava to lead go-to-market for a new line of business. Earlier in his career,
Brian was an analyst at a EverBank and a B2B marketing consultant at a leading Hubspot part-
ner agency. Brian earned his B.A. from the University of Vermont where he studied Economics,
Business Administration, and Computer Science.

16
Yasmin Cruz Ferrine
Co-Founder and General Partner, Visible Hands
Yasmin Cruz Ferrine (she/her/hers) is a General Partner and Co-Founder at Visible Hands VC,
a pre-seed fund and fellowship program that supports overlooked talent in building venture
backed technology startups by providing company-building services and investments of up to
$200K. Yasmin has 15 years of experience leading capital raising, investment strategies, and
advising foundations. Yasmin’s career includes cross-sector experiences from the 2020 US
presidential election campaign to Head of Growth and Strategy New England region at Brown
Advisory to Director of Corporate Responsibility at John Hancock. Yasmin began her career
as a buy-side small-cap equity analyst. Yasmin’s current board work includes the Social Inno-
vation Forum and Museum of Fine Arts, Boston. Yasmin earned her MBA from Boston College
and Bachelor of Science degree from Babson College.
Lydia Jett
Managing Partner, SoftBank Vision Fund
Lydia Jett is a Managing Partner at SoftBank Investment Advisers (SBIA) where she helps
lead the firm’s US Consumer Internet and Global eCommerce Sectors. Lydia has led and rep-
resents Softbank on the Board of Directors of the firm’s global eCommerce investments in-
cluding Coupang (NYSE: CPNG), Fanatics, Flipkart and GoTo. Additionally, Lydia has led and
represents Softbank on the Board of Directors of Andela, Block, Candy, Embark, Klook, LTK,
Misfits Market, mmhmm, Pacaso, Papa, Perch, The Sandbox. Prior to SBIA , Lydia was a senior
member of the investment team at SoftBank Group Corp International where she led SBGl’s
investments in Guardant Health (Nasdaq: GH), l0X Genomics (Nasdaq: TXG) and Fetch Robot-
ics (sale to Zebra) and represented Softbank on the board of inMobi. Previously, Lydia was a
Vice President at M/C Partners, a growth equity firm, and an Associate at Goldman Sachs in
the Principal Investment Area where she invested across media and technology sectors. She
started her career at JPMorgan. In addition, she is an independent board member of Ozan
(Nasdaq: Ozan) and on the Venture Advisory Board of Silicon Valley Bank. Lydia is a graduate
of the Stanford Graduate School of Business, the London School of Economics and Smith
College.
16
Yasmin Cruz Ferrine
Co-Founder and General Partner, Visible Hands
Yasmin Cruz Ferrine (she/her/hers) is a General Partner and Co-Founder at Visible Hands VC,
a pre-seed fund and fellowship program that supports overlooked talent in building venture
backed technology startups by providing company-building services and investments of up to
$200K. Yasmin has 15 years of experience leading capital raising, investment strategies, and
advising foundations. Yasmin’s career includes cross-sector experiences from the 2020 US
presidential election campaign to Head of Growth and Strategy New England region at Brown
Advisory to Director of Corporate Responsibility at John Hancock. Yasmin began her career
as a buy-side small-cap equity analyst. Yasmin’s current board work includes the Social Inno-
vation Forum and Museum of Fine Arts, Boston. Yasmin earned her MBA from Boston College
and Bachelor of Science degree from Babson College.
Lydia Jett
Managing Partner, SoftBank Vision Fund
Lydia Jett is a Managing Partner at SoftBank Investment Advisers (SBIA) where she helps
lead the firm’s US Consumer Internet and Global eCommerce Sectors. Lydia has led and rep-
resents Softbank on the Board of Directors of the firm’s global eCommerce investments in-
cluding Coupang (NYSE: CPNG), Fanatics, Flipkart and GoTo. Additionally, Lydia has led and
represents Softbank on the Board of Directors of Andela, Block, Candy, Embark, Klook, LTK,
Misfits Market, mmhmm, Pacaso, Papa, Perch, The Sandbox. Prior to SBIA , Lydia was a senior
member of the investment team at SoftBank Group Corp International where she led SBGl’s
investments in Guardant Health (Nasdaq: GH), l0X Genomics (Nasdaq: TXG) and Fetch Robot-
ics (sale to Zebra) and represented Softbank on the board of inMobi. Previously, Lydia was a
Vice President at M/C Partners, a growth equity firm, and an Associate at Goldman Sachs in
the Principal Investment Area where she invested across media and technology sectors. She
started her career at JPMorgan. In addition, she is an independent board member of Ozan
(Nasdaq: Ozan) and on the Venture Advisory Board of Silicon Valley Bank. Lydia is a graduate
of the Stanford Graduate School of Business, the London School of Economics and Smith
College.

Marlon Nichols
Founder and Managing Partner, Mac Venture Capital
Marlon Nichols is a founding managing partner at MaC Venture Capital (formerly Cross Cul-
ture Ventures), which finds entrepreneurs who are building the future for the rest of America.
He’s a former Investment Director at Intel Capital. He is Kauffman Fellows board member
and adjunct in entrepreneurship and venture capital at the SC Johnson College of Business
at Cornell University. Marlon’s unique eye for global trends and shifts in consumer behavior
has helped him capture high-potential investments like Blavity, Fair, Faze Clan, Gimlet Media,
LISNR, Mayvenn, MongoDB, Pipe, PlayVS, Thrive Market, Wonderschool and others. He’s been
featured on TechCrunch, Fortune, Blavity, and NBC, and was the recipient of MVMT50’s SXSW
2018 Innovator of the Year award, Digital Diversity’s Innovation & Inclusion Change Agent
award, and was named Pitchbook’s 25 Black Founders and VCs to Watch in 2018 and 2019.
Marlon Nichols
Founder and Managing Partner, Mac Venture Capital
Marlon Nichols is a founding managing partner at MaC Venture Capital (formerly Cross Cul-
ture Ventures), which finds entrepreneurs who are building the future for the rest of America.
He’s a former Investment Director at Intel Capital. He is Kauffman Fellows board member
and adjunct in entrepreneurship and venture capital at the SC Johnson College of Business
at Cornell University. Marlon’s unique eye for global trends and shifts in consumer behavior
has helped him capture high-potential investments like Blavity, Fair, Faze Clan, Gimlet Media,
LISNR, Mayvenn, MongoDB, Pipe, PlayVS, Thrive Market, Wonderschool and others. He’s been
featured on TechCrunch, Fortune, Blavity, and NBC, and was the recipient of MVMT50’s SXSW
2018 Innovator of the Year award, Digital Diversity’s Innovation & Inclusion Change Agent
award, and was named Pitchbook’s 25 Black Founders and VCs to Watch in 2018 and 2019.

18
India | 10:00 – 10:50am | Ensemble E
18
INDIA
10:00 – 10:50am | Ensemble E
Indiahasreceivedhugeamountofcapitalinthetechecosystemfrombothdomesticand
international funds over the last few years. Certain sectors such as consumer, fintech
and Saas have been leading the way. The strength of the investing ecosystem in India
has driven real economic value for the country and played a pivotal role in placing the
Indian startups - only behind some of the largest tech ecosystems in the world (US and
China). Rising smartphone penetration, access to cheap internet data, digitization push
due to COVID-19 lockdowns, have all led to high-growth and high performing startups.
TherehavealsobeentailwindssupportingexitsfortechstartupsinIndiawithmajorIPOs
happen through 2021.
PANEL CAPTAIN: Arushi Jindal
18
18
INDIA
10:00 – 10:50am | Ensemble E
Indiahasreceivedhugeamountofcapitalinthetechecosystemfrombothdomesticand
international funds over the last few years. Certain sectors such as consumer, fintech
and Saas have been leading the way. The strength of the investing ecosystem in India
has driven real economic value for the country and played a pivotal role in placing the
Indian startups - only behind some of the largest tech ecosystems in the world (US and
China). Rising smartphone penetration, access to cheap internet data, digitization push
due to COVID-19 lockdowns, have all led to high-growth and high performing startups.
TherehavealsobeentailwindssupportingexitsfortechstartupsinIndiawithmajorIPOs
happen through 2021.
PANEL CAPTAIN: Arushi Jindal

Vikram Gandhi [MODERATOR]
Vikram Gandhi is a Senior Lecturer at Harvard Business School where he teaches in the MBA
and Executive Education Programs. He is the Founder of Asha Impact, Chairman of the Board
of the Growth for Good SPAC, is a Senior Advisor to the Canadian Pension Plan, and has 23
years of experience in investment banking at Morgan Stanley and Credit Suisse.
Kaushik Anand
Partner, A91 Partners
Kaushik is a Partner at A91 Partners where he focuses on technology and financial services
business. Previously, Kaushik set up CapitalG (formerly Google Capital) in India and was its
India Head. He has been involved with investments in Digit, Inshorts, Exotel, Freshworks, Aye
Finance and Cardekho over the last decade. He was previously at Sequoia Capital India and
McKinsey & Co. He is an alumnus of Harvard Business School and IIT Madras.
Dev Khare
Partner, Lightspeed
Dev has spent 20+ years in the world of technology startups. After a decade spent living in
India, Dev is currently based in the San Francisco Bay Area with Lightspeed India, focusing on
India-originated globally-facing SaaS investments.Since joining Lightspeed India in 2011, Dev
has invested in consumer and enterprise companies that have low-friction, software-based
models. His SaaS investments include Acceldata, Darwinbox, Innovaccer, Okcredit, Revv.so
and Yellow.ai. His consumer investments include Byju’s and Sharechat.
Dev moved to Silicon Valley in 1998 where he was a product manager for CrossWorlds, an en-
terprise applications integration software company, and then founded Covigo, an enterprise
platform for mobile applications. Covigo was acquired by NYSE-traded Symbol Technologies.
Post Symbol, in 2006, Dev joined early-stage venture fund Venrock in Silicon Valley where he
invested in one of India’s early Internet successes: Slideshare, acquired by Linkedin.
Vikram Gandhi [MODERATOR]
Vikram Gandhi is a Senior Lecturer at Harvard Business School where he teaches in the MBA
and Executive Education Programs. He is the Founder of Asha Impact, Chairman of the Board
of the Growth for Good SPAC, is a Senior Advisor to the Canadian Pension Plan, and has 23
years of experience in investment banking at Morgan Stanley and Credit Suisse.
Kaushik Anand
Partner, A91 Partners
Kaushik is a Partner at A91 Partners where he focuses on technology and financial services
business. Previously, Kaushik set up CapitalG (formerly Google Capital) in India and was its
India Head. He has been involved with investments in Digit, Inshorts, Exotel, Freshworks, Aye
Finance and Cardekho over the last decade. He was previously at Sequoia Capital India and
McKinsey & Co. He is an alumnus of Harvard Business School and IIT Madras.
Dev Khare
Partner, Lightspeed
Dev has spent 20+ years in the world of technology startups. After a decade spent living in
India, Dev is currently based in the San Francisco Bay Area with Lightspeed India, focusing on
India-originated globally-facing SaaS investments.Since joining Lightspeed India in 2011, Dev
has invested in consumer and enterprise companies that have low-friction, software-based
models. His SaaS investments include Acceldata, Darwinbox, Innovaccer, Okcredit, Revv.so
and Yellow.ai. His consumer investments include Byju’s and Sharechat.
Dev moved to Silicon Valley in 1998 where he was a product manager for CrossWorlds, an en-
terprise applications integration software company, and then founded Covigo, an enterprise
platform for mobile applications. Covigo was acquired by NYSE-traded Symbol Technologies.
Post Symbol, in 2006, Dev joined early-stage venture fund Venrock in Silicon Valley where he
invested in one of India’s early Internet successes: Slideshare, acquired by Linkedin.

20
He graduated from Penn/Wharton in 1994 with degrees in computer science and finance and
from Harvard Business School in 1998.
Puneet Kumar
Managing Director, Steadview Capital
Puneet is currently Managing Director at Steadview Capital, focusing on their India private
investments. Steadview manages $5b+ with more than $2.5b invested in private tech in India.
Stedaview had 5 IPOs in 2021 including Zomato, Nykaa, Policybazar and Freshworks. Prior
to Steadview, Puneet worked at Nexus venture partners for 2.5 years doing early-stage tech
investing. He has invested across sectors in India from SaaS to Gaming to E-commerce over
the last 5 years. He worked at McKinsey in the US prior to moving back to India. He did his
undergrad at IIT Madras and MBA at Stanford GSB. He grew up in a small village in Rajasthan
and spent the first 18 years of his life there.
Anant Vidur Puri
Managing Director, Bessemer
Anant Vidur Puri is a partner in the Bangalore office where he focuses on high potential oppor-
tunities in Internet Marketplaces and India SaaS.
Prior to joining Bessemer, Anant was at Boston Consulting Group where he worked with cli-
ents in financial and IT services across India and North America.
Anant graduated with a degree in electrical engineering from IIT Delhi where he focused on
computer and machine vision. He also received an MBA from Harvard Business School where
he was also on the Student Senate. Outside of work, Anant enjoys reading fantasy fiction,
mythology (Indian, Greek, Roman, Norse), playing tennis, and traveling to places of historical
significance.
20
He graduated from Penn/Wharton in 1994 with degrees in computer science and finance and
from Harvard Business School in 1998.
Puneet Kumar
Managing Director, Steadview Capital
Puneet is currently Managing Director at Steadview Capital, focusing on their India private
investments. Steadview manages $5b+ with more than $2.5b invested in private tech in India.
Stedaview had 5 IPOs in 2021 including Zomato, Nykaa, Policybazar and Freshworks. Prior
to Steadview, Puneet worked at Nexus venture partners for 2.5 years doing early-stage tech
investing. He has invested across sectors in India from SaaS to Gaming to E-commerce over
the last 5 years. He worked at McKinsey in the US prior to moving back to India. He did his
undergrad at IIT Madras and MBA at Stanford GSB. He grew up in a small village in Rajasthan
and spent the first 18 years of his life there.
Anant Vidur Puri
Managing Director, Bessemer
Anant Vidur Puri is a partner in the Bangalore office where he focuses on high potential oppor-
tunities in Internet Marketplaces and India SaaS.
Prior to joining Bessemer, Anant was at Boston Consulting Group where he worked with cli-
ents in financial and IT services across India and North America.
Anant graduated with a degree in electrical engineering from IIT Delhi where he focused on
computer and machine vision. He also received an MBA from Harvard Business School where
he was also on the Student Senate. Outside of work, Anant enjoys reading fantasy fiction,
mythology (Indian, Greek, Roman, Norse), playing tennis, and traveling to places of historical
significance.

10:00 – 10:50am | Ensemble F
2022 kicks off with turbulent public markets for biotech while private markets are flush
with capital. Big pharma has record-high cash sitting on the sidelines, but M&A has not
yet picked up. What does this portend for the year ahead? How are VCs re-evaluating
their investment approaches? This panel will cover macro trends in the life sciences
industry, predictions for the year ahead, and advice for entrepreneurs and investors in
the biotech space.
PANEL CAPTAINS: Kevin Huang and Adam Ingber
10:00 – 10:50am | Ensemble F
2022 kicks off with turbulent public markets for biotech while private markets are flush
with capital. Big pharma has record-high cash sitting on the sidelines, but M&A has not
yet picked up. What does this portend for the year ahead? How are VCs re-evaluating
their investment approaches? This panel will cover macro trends in the life sciences
industry, predictions for the year ahead, and advice for entrepreneurs and investors in
the biotech space.
PANEL CAPTAINS: Kevin Huang and Adam Ingber

22
Life Sciences & Biotech | 10:00 – 10:50am | Ensemble F
Eric S. Siegel [MODERATOR]
Partner, Dechert
Eric S. Siegel represents financial sponsors and their portfolio companies as well as strategic
buyers and sellers in domestic and cross-border M&A and joint venture transactions across
a wide range of industry sectors, including healthcare, technology, financial services, energy
and manufacturing. In addition, he advises new and seasoned issuers as well as major invest-
ment banks in connection with securities offerings of equity and debt.
Mr. Siegel also advises clients on the full range of general corporate matters, including corpo-
rate governance and securities law compliance matters, SEC disclosure filings and the prepa-
ration of annual and quarterly reports and proxy statements.
Mr. Siegel received his J.D. from Harvard Law School and his B.A. from the University of
Pennsylvania.
Shaan C. Gandhi, M.D., D.Phil.
Director, Northpond Ventures
Shaan C. Gandhi is a Director at Northpond Ventures on the firm’s biotechnologies team.
Shaan is a Board Director at public and private companies including CAMP4 Therapeutics,
Candel Therapeutics (NASDAQ: CADL), DICE Therapeutics (NASDAQ: DICE), Garuda Thera-
peutics, Mestag Therapeutics, Parthenon Therapeutics, Totus Medicines, and Vigil Neurosci-
ence (NASDAQ: VIGL). Previously, Shaan was a Principal at the Longwood Fund, where he
created and invested in life sciences companies, including Pyxis Oncology (NASDAQ: PYXS),
an antibody-drug conjugate and monoclonal antibody oncology company, which he co-found-
ed and served as President. Prior to Longwood, he was an attending hospitalist at Massachu-
setts General Hospital, where he also did his residency in internal medicine. He holds an M.D.
from Harvard Medical School; an MBA from Harvard Business School, where he was a Baker
Scholar; a D.Phil. in medical oncology from the University of Oxford, where he was a Rhodes
Scholar; and a B.S. with honors in biochemistry from Case Western Reserve University. Shaan
is the Vice President of the Suffolk District Medical Society, the professional medical society
of Boston, and a Trustee of the Boston Medical Library.
22
Eric S. Siegel [MODERATOR]
Partner, Dechert
Eric S. Siegel represents financial sponsors and their portfolio companies as well as strategic
buyers and sellers in domestic and cross-border M&A and joint venture transactions across
a wide range of industry sectors, including healthcare, technology, financial services, energy
and manufacturing. In addition, he advises new and seasoned issuers as well as major invest-
ment banks in connection with securities offerings of equity and debt.
Mr. Siegel also advises clients on the full range of general corporate matters, including corpo-
rate governance and securities law compliance matters, SEC disclosure filings and the prepa-
ration of annual and quarterly reports and proxy statements.
Mr. Siegel received his J.D. from Harvard Law School and his B.A. from the University of
Pennsylvania.
Shaan C. Gandhi, M.D., D.Phil.
Director, Northpond Ventures
Shaan C. Gandhi is a Director at Northpond Ventures on the firm’s biotechnologies team.
Shaan is a Board Director at public and private companies including CAMP4 Therapeutics,
Candel Therapeutics (NASDAQ: CADL), DICE Therapeutics (NASDAQ: DICE), Garuda Thera-
peutics, Mestag Therapeutics, Parthenon Therapeutics, Totus Medicines, and Vigil Neurosci-
ence (NASDAQ: VIGL). Previously, Shaan was a Principal at the Longwood Fund, where he
created and invested in life sciences companies, including Pyxis Oncology (NASDAQ: PYXS),
an antibody-drug conjugate and monoclonal antibody oncology company, which he co-found-
ed and served as President. Prior to Longwood, he was an attending hospitalist at Massachu-
setts General Hospital, where he also did his residency in internal medicine. He holds an M.D.
from Harvard Medical School; an MBA from Harvard Business School, where he was a Baker
Scholar; a D.Phil. in medical oncology from the University of Oxford, where he was a Rhodes
Scholar; and a B.S. with honors in biochemistry from Case Western Reserve University. Shaan
is the Vice President of the Suffolk District Medical Society, the professional medical society
of Boston, and a Trustee of the Boston Medical Library.

Arjun Goyal
Managing Director, Vida Ventures
Dr. Arjun Goyal is a Co-Founder and Managing Director of Vida Ventures, a leading US-based
life sciences venture capital firm with approximately $1.7 billion in AUM. Arjun focuses on
creating and investing in companies that translate groundbreaking science into innovative
medicines. He serves as a director on the boards of Scorpion Therapeutics, Quanta Therapeu-
tics, Affini-T and Centessa Pharmaceuticals (NASDAQ: CNTA) and has played key roles in Vida
Venture’s investments in Homology Medicines (NASDAQ:FIXX), Pionyr Immunotherapeutics
(acquired by Gilead), Peloton Therapeutics (acquired by Merck & Co.), and Asklepios Bio (ac-
quired by Bayer).
Before co-founding Vida Ventures in 2017, Arjun was a life sciences investor at 5AM Ventures.
Arjun received his B.Sc. in Medical Science, Diploma in French and his MBBS degree from
the Universities of Melbourne and Oxford. He completed his postgraduate clinical training in
Internal Medicine in Sydney. He received his M.Phil. in Bioscience Enterprise from University
of Cambridge and his MBA from Harvard Business School.
Luba Greenwood
Partner, Binney Street Capital
Luba is a veteran biotech, pharmaceutical, tech, and life sciences investor and company build-
er. Luba serves as the Managing Partner of the Dana Farber Cancer Institute Venture Fund,
Binney Street Capital (BSC), which she has built and launched. She is also the CEO of one
of BSC’s portfolio companies Kojin Therapeutics, which is discovering and developing novel
therapeutics in oncology, fibrosis, and immune modulation. She is a professor at Harvard
University in the School of Engineering and Applied Sciences.
Luba has previously served in leadership roles at Google Life Sciences (Verily) and as Vice
President of Global Business Development and Mergers & Acquisitions at Roche, where she
also established and led the East Coast Innovation Hub. Luba has led $5B+ in deals and invest-
ments across multiple therapeutic areas and life sciences and tech sectors globally. She has
also co-founded biotech and digital health companies in the immunotherapy, AI/ML, women’s
health and microbiome space, including Luca Biologics.
Arjun Goyal
Managing Director, Vida Ventures
Dr. Arjun Goyal is a Co-Founder and Managing Director of Vida Ventures, a leading US-based
life sciences venture capital firm with approximately $1.7 billion in AUM. Arjun focuses on
creating and investing in companies that translate groundbreaking science into innovative
medicines. He serves as a director on the boards of Scorpion Therapeutics, Quanta Therapeu-
tics, Affini-T and Centessa Pharmaceuticals (NASDAQ: CNTA) and has played key roles in Vida
Venture’s investments in Homology Medicines (NASDAQ:FIXX), Pionyr Immunotherapeutics
(acquired by Gilead), Peloton Therapeutics (acquired by Merck & Co.), and Asklepios Bio (ac-
quired by Bayer).
Before co-founding Vida Ventures in 2017, Arjun was a life sciences investor at 5AM Ventures.
Arjun received his B.Sc. in Medical Science, Diploma in French and his MBBS degree from
the Universities of Melbourne and Oxford. He completed his postgraduate clinical training in
Internal Medicine in Sydney. He received his M.Phil. in Bioscience Enterprise from University
of Cambridge and his MBA from Harvard Business School.
Luba Greenwood
Partner, Binney Street Capital
Luba is a veteran biotech, pharmaceutical, tech, and life sciences investor and company build-
er. Luba serves as the Managing Partner of the Dana Farber Cancer Institute Venture Fund,
Binney Street Capital (BSC), which she has built and launched. She is also the CEO of one
of BSC’s portfolio companies Kojin Therapeutics, which is discovering and developing novel
therapeutics in oncology, fibrosis, and immune modulation. She is a professor at Harvard
University in the School of Engineering and Applied Sciences.
Luba has previously served in leadership roles at Google Life Sciences (Verily) and as Vice
President of Global Business Development and Mergers & Acquisitions at Roche, where she
also established and led the East Coast Innovation Hub. Luba has led $5B+ in deals and invest-
ments across multiple therapeutic areas and life sciences and tech sectors globally. She has
also co-founded biotech and digital health companies in the immunotherapy, AI/ML, women’s
health and microbiome space, including Luca Biologics.

24
She has served on multiple public, private, and non-profit boards, including the Massachu-
setts Biotechnology Council (MassBio), Kojin Tx, Brooklyn ImmunoTherapeutics, BenchSci,
In8Bio, and OS Fund, a SPAC. She has advised leading academic centers globally including
the CEO of the Dana-Farber Cancer Institute as well as the Director of the Wyss Center for Bio
and Neuroengineering in Geneva. She is a Thought Leader for the New England Journal of
Medicine (NEJM) Catalyst and serves on Investor Committee for the National Cancer Institute.
Luba is also a former litigator and regulatory, policy, and IP expert, having started her career
at Wilmer Cutler Pickering Hale and Dorr. She is a recipient of several awards and honors for
her work in the community, including the Science Club for Girls Catalyst Award for her com-
mitment to advocating for women in science and technology.
Adam M. Koppel
Managing Director, Bain Capital
Adam M. Koppel rejoined Bain Capital in 2016 as Managing Director of Bain Capital Life Sci-
ences. He initially joined Bain Capital Public Equity in 2003 where he worked as a leader within
the healthcare sector until 2014. From 2014 to 2016, Dr. Koppel was EVP of Corporate De-
velopment and Chief Strategy Officer at Biogen. He sits on the Board of Directors of Aptinyx
(NASD: APTX), Cardurion Pharmaceuticals, Cerevel Therapeutics (NASD: CERE), Dicerna
Pharmaceuticals (NASD: DRNA), Foghorn Therapeutics (NASD: FHTX) and Solid Biosciences
(NASD: SLDB) and is a Board Observer for AavantiBio and ViaCyte.
Prior to initially joining Bain Capital in 2003, Dr. Koppel was an Associate Principal at McKinsey
& Co in New Jersey where he served a variety of healthcare companies.
Dr. Koppel sits on the Newton-Wellesley Hospital Board of Trustees, the Boston Museum of
Science Board of Trustees, the Partners Healthcare Innovation Advisory Board, and the Soci-
ety for Neuroscience Investment Committee. In addition, he sits on the Gann Academy Board
of Trustees and CJP’s Budget and Administration Committee. He previously sat on the Board
of Temple Beth Elohim in Wellesley MA, from 2014-2017.
Dr. Koppel received an M.D. and PhD in Neuroscience from the University of Pennsylvania
School of Medicine. He also received an MBA from The Wharton School at the University of
Pennsylvania, where he was a Palmer Scholar. He graduated magna cum laude from Harvard
University with an A.B. and A.M. in History and Science.
24
She has served on multiple public, private, and non-profit boards, including the Massachu-
setts Biotechnology Council (MassBio), Kojin Tx, Brooklyn ImmunoTherapeutics, BenchSci,
In8Bio, and OS Fund, a SPAC. She has advised leading academic centers globally including
the CEO of the Dana-Farber Cancer Institute as well as the Director of the Wyss Center for Bio
and Neuroengineering in Geneva. She is a Thought Leader for the New England Journal of
Medicine (NEJM) Catalyst and serves on Investor Committee for the National Cancer Institute.
Luba is also a former litigator and regulatory, policy, and IP expert, having started her career
at Wilmer Cutler Pickering Hale and Dorr. She is a recipient of several awards and honors for
her work in the community, including the Science Club for Girls Catalyst Award for her com-
mitment to advocating for women in science and technology.
Adam M. Koppel
Adam M. Koppel rejoined Bain Capital in 2016 as Managing Director of Bain Capital Life Sci-
ences. He initially joined Bain Capital Public Equity in 2003 where he worked as a leader within
the healthcare sector until 2014. From 2014 to 2016, Dr. Koppel was EVP of Corporate De-
velopment and Chief Strategy Officer at Biogen. He sits on the Board of Directors of Aptinyx
(NASD: APTX), Cardurion Pharmaceuticals, Cerevel Therapeutics (NASD: CERE), Dicerna
Pharmaceuticals (NASD: DRNA), Foghorn Therapeutics (NASD: FHTX) and Solid Biosciences
(NASD: SLDB) and is a Board Observer for AavantiBio and ViaCyte.
Prior to initially joining Bain Capital in 2003, Dr. Koppel was an Associate Principal at McKinsey
& Co in New Jersey where he served a variety of healthcare companies.
Dr. Koppel sits on the Newton-Wellesley Hospital Board of Trustees, the Boston Museum of
Science Board of Trustees, the Partners Healthcare Innovation Advisory Board, and the Soci-
ety for Neuroscience Investment Committee. In addition, he sits on the Gann Academy Board
of Trustees and CJP’s Budget and Administration Committee. He previously sat on the Board
of Temple Beth Elohim in Wellesley MA, from 2014-2017.
Dr. Koppel received an M.D. and PhD in Neuroscience from the University of Pennsylvania
School of Medicine. He also received an MBA from The Wharton School at the University of
Pennsylvania, where he was a Palmer Scholar. He graduated magna cum laude from Harvard
University with an A.B. and A.M. in History and Science.

Christoph Westphal
Co-founder and General Partner, Longwood Fund
Dr. Westphal is co-founder and General Partner of Longwood Fund and has spent 20 years
as a biotech CEO, entrepreneur, and investor. Dr. Westphal has been the co-founder, CEO, and
lead investor of seven biotechnology companies that have completed initial public offerings
(IPOs) and created sustained market value of over $40 billion and have developed and re-
ceived FDA approval for over 10 important drugs. These include: Momenta Pharmaceuticals,
Inc. (NASDAQ: MNTA), Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), Acceleron Pharma,
Inc. (NASDAQ: XLRN), Sirtris Pharmaceuticals, Inc. (NASDAQ: SIRT, acquired by GSK in 2008),
Verastem (NASDAQ: VSTM), and TScan Therapeutics (NASDAQ: TCRX). Dr. Westphal is also
co-founder of Alnara Pharmaceuticals (acquired by Eli Lilly); co-founder/Executive Chair of
ImmuneID; co-founder/former CEO/Chair of Immunitas Therapeutics; co-founder of Pyxis On-
cology; and co-founder of Concert Pharmaceuticals (NASDAQ: CNCE).
Dr. Westphal earned his M.D. from Harvard Medical School and PhD in genetics from Harvard
University; and he graduated with a B.A. summa cum laude and Phi Beta Kappa from Colum-
bia University. Dr. Westphal has served or currently serves as a member or director of: the
Boston Commercial Club, the Biotechnology Industry Organization’s (BIO) Emerging Compa-
nies Section Governing Board, the Board of Fellows of Harvard Medical School, and the Board
of Trustees of the Boston Symphony Orchestra; he is also a member of the ownership group
of the Boston Celtics.
Christoph Westphal
Co-founder and General Partner, Longwood Fund
Dr. Westphal is co-founder and General Partner of Longwood Fund and has spent 20 years
as a biotech CEO, entrepreneur, and investor. Dr. Westphal has been the co-founder, CEO, and
lead investor of seven biotechnology companies that have completed initial public offerings
(IPOs) and created sustained market value of over $40 billion and have developed and re-
ceived FDA approval for over 10 important drugs. These include: Momenta Pharmaceuticals,
Inc. (NASDAQ: MNTA), Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), Acceleron Pharma,
Inc. (NASDAQ: XLRN), Sirtris Pharmaceuticals, Inc. (NASDAQ: SIRT, acquired by GSK in 2008),
Verastem (NASDAQ: VSTM), and TScan Therapeutics (NASDAQ: TCRX). Dr. Westphal is also
co-founder of Alnara Pharmaceuticals (acquired by Eli Lilly); co-founder/Executive Chair of
ImmuneID; co-founder/former CEO/Chair of Immunitas Therapeutics; co-founder of Pyxis On-
cology; and co-founder of Concert Pharmaceuticals (NASDAQ: CNCE).
Dr. Westphal earned his M.D. from Harvard Medical School and PhD in genetics from Harvard
University; and he graduated with a B.A. summa cum laude and Phi Beta Kappa from Colum-
bia University. Dr. Westphal has served or currently serves as a member or director of: the
Boston Commercial Club, the Biotechnology Industry Organization’s (BIO) Emerging Compa-
nies Section Governing Board, the Board of Fellows of Harvard Medical School, and the Board
of Trustees of the Boston Symphony Orchestra; he is also a member of the ownership group
of the Boston Celtics.

26
Managing a Career in Investing | 10:00 – 10:50am | Ensemble G
26
10:00 – 10:50am | Ensemble G
Whether differentiating yourself in an investing interview or a potential LP meeting,
your candidacy is evaluated on how your experiences translate to the task at hand. As
experiences in work and life have become increasingly intertwined, what investors do
outsideofworkdirectlyaffectstheirperformance,investingexpertise,andjobsatisfaction.
Wewillexplorehowourpanelistshavefoundbalanceintheirinvestingcareers,andhow
their own personal pursuits have fueled their own performance and management skills
at work.
PANEL CAPTAIN: Zoe Zabor
26
26
10:00 – 10:50am | Ensemble G
Whether differentiating yourself in an investing interview or a potential LP meeting,
your candidacy is evaluated on how your experiences translate to the task at hand. As
experiences in work and life have become increasingly intertwined, what investors do
outsideofworkdirectlyaffectstheirperformance,investingexpertise,andjobsatisfaction.
Wewillexplorehowourpanelistshavefoundbalanceintheirinvestingcareers,andhow
their own personal pursuits have fueled their own performance and management skills
at work.
PANEL CAPTAIN: Zoe Zabor

Eric Anderson
Partner, Scale Venture Partners
Eric is a Partner at Scale Venture Partners, where he focuses on investments in cloud infra-
structure and security. He is a Board member at Scale portfolio companies Datastax and
Upsolver, and a Board observer at Matillion, BigID, Expel, Honeycomb, Tetrate, and AppOmni.
Before Scale, Eric led early Google Cloud and Amazon Web Services product teams. At Goo-
gle, he was a Product Manager in the Data Analytics and Machine Learning group. He led the
team that launched Cloud Dataprep and key components of Cloud Dataflow. Previously, Eric
built aircraft engines in General Electric’s Operation Management Leadership Program. He’s a
contributor to open source projects including Alluxio, where he is on the Project Management
Committee, and Apache Beam.
Eric holds a B.S. in Mechanical Engineering from University of Utah and an MBA from Harvard
Business School. He is the creator and host of Contributor, an interview series detailing the
origin stories of open source projects.
Jadyn Bryden
Vice President, Xfund
Jadyn is a Vice President at Xfund. Prior to Xfund, she was the Chief Strategy Officer of Har-
vard Student Agencies (HSA), the largest student-run company in the world, with 12 separate
business units, over 600 employees and over 50 managers. Leading up to her role as the CSO,
Jadyn was the Chief People Officer of HSA. In her years in the C-suite, she led the strategic
development of the company, updated the compliance standards of the business, and drove
innovation at the company which resulted in the creation of new agencies.
Over the course of her time at Harvard, Jadyn was a co-founder of organizations including
Harvard Giving Pledge and Harvard College Symphony Society. With her entrepreneurial in-
terests, she has advised her peers in startups on campus in collaboration with the Harvard
Innovation Labs.
Eric Anderson
Partner, Scale Venture Partners
Eric is a Partner at Scale Venture Partners, where he focuses on investments in cloud infra-
structure and security. He is a Board member at Scale portfolio companies Datastax and
Upsolver, and a Board observer at Matillion, BigID, Expel, Honeycomb, Tetrate, and AppOmni.
Before Scale, Eric led early Google Cloud and Amazon Web Services product teams. At Goo-
gle, he was a Product Manager in the Data Analytics and Machine Learning group. He led the
team that launched Cloud Dataprep and key components of Cloud Dataflow. Previously, Eric
built aircraft engines in General Electric’s Operation Management Leadership Program. He’s a
contributor to open source projects including Alluxio, where he is on the Project Management
Committee, and Apache Beam.
Eric holds a B.S. in Mechanical Engineering from University of Utah and an MBA from Harvard
Business School. He is the creator and host of Contributor, an interview series detailing the
origin stories of open source projects.
Jadyn Bryden
Vice President, Xfund
Jadyn is a Vice President at Xfund. Prior to Xfund, she was the Chief Strategy Officer of Har-
vard Student Agencies (HSA), the largest student-run company in the world, with 12 separate
business units, over 600 employees and over 50 managers. Leading up to her role as the CSO,
Jadyn was the Chief People Officer of HSA. In her years in the C-suite, she led the strategic
development of the company, updated the compliance standards of the business, and drove
innovation at the company which resulted in the creation of new agencies.
Over the course of her time at Harvard, Jadyn was a co-founder of organizations including
Harvard Giving Pledge and Harvard College Symphony Society. With her entrepreneurial in-
terests, she has advised her peers in startups on campus in collaboration with the Harvard
Innovation Labs.

28
David Eisenberg
Founder and Managing Director, Zigg Capital
David Eisenberg is the Founder and Managing Director of Zigg Capital, a venture capital fund
focused on the real estate and construction industries. Representative early stage invest-
ments of his include Procore, Juniper Square, VTS, Matterport and Snapdocs. Prior to found-
ing Zigg, he served as the Global SVP of Technology of CBRE. He joined CBRE as a result of it
acquisition of Floored, a commercial real estate software company founded by Mr. Eisenberg
and led by him as its Chief Executive Officer from 2012-2017. Earlier in Mr. Eisenberg’s career,
he was a founding team member of two other retail technology businesses, TellApart (later
acquired by Twitter) and Bonobos (later acquired by Walmart). Mr. Eisenberg started his ca-
reer at Bain & Company and graduated from Harvard. Mr. Eisenberg also serves on the Board
of Directors of iStar (NYSE: STAR).
Constance Freedman
Founder and Managing Partner, Moderne Ventures
Constance Freedman is the Founder and Managing Partner of Moderne Ventures and the
Moderne Passport, an early stage investment fund and industry immersion program which is
focused on investing in technology companies in and around the multi-trillion dollar industries
of real estate, finance, insurance, hospitality and home services.
Moderne Ventures recently closed on an oversubscribed $200M Fund bringing the firm to
more than $350M AUM. Moderne has invested in over 100 companies and actively partners
with 700+ industry executives and corporations to help build strategic value and scale. Ms.
Freedman’s initial two funds have produced 4 IPOs (+ 1 IPO pending), 6 Unicorns, 11 up-
rounds this past year alone and many successful exits. Constance is active on several com-
pany boards, past and present, including DocuSign [NASDAQ: DOCU], Porch [NASDAQ: PRCH],
Homesnap (acquired by CoStar), Equity Lifestyles [NYSE:ELS] and ICON.
Mr. Freedman earned a B.S. from Boston University and a MBA from Harvard Business School.
28
David Eisenberg
Founder and Managing Director, Zigg Capital
David Eisenberg is the Founder and Managing Director of Zigg Capital, a venture capital fund
focused on the real estate and construction industries. Representative early stage invest-
ments of his include Procore, Juniper Square, VTS, Matterport and Snapdocs. Prior to found-
ing Zigg, he served as the Global SVP of Technology of CBRE. He joined CBRE as a result of it
acquisition of Floored, a commercial real estate software company founded by Mr. Eisenberg
and led by him as its Chief Executive Officer from 2012-2017. Earlier in Mr. Eisenberg’s career,
he was a founding team member of two other retail technology businesses, TellApart (later
acquired by Twitter) and Bonobos (later acquired by Walmart). Mr. Eisenberg started his ca-
reer at Bain & Company and graduated from Harvard. Mr. Eisenberg also serves on the Board
of Directors of iStar (NYSE: STAR).
Constance Freedman
Founder and Managing Partner, Moderne Ventures
Constance Freedman is the Founder and Managing Partner of Moderne Ventures and the
Moderne Passport, an early stage investment fund and industry immersion program which is
focused on investing in technology companies in and around the multi-trillion dollar industries
of real estate, finance, insurance, hospitality and home services.
Moderne Ventures recently closed on an oversubscribed $200M Fund bringing the firm to
more than $350M AUM. Moderne has invested in over 100 companies and actively partners
with 700+ industry executives and corporations to help build strategic value and scale. Ms.
Freedman’s initial two funds have produced 4 IPOs (+ 1 IPO pending), 6 Unicorns, 11 up-
rounds this past year alone and many successful exits. Constance is active on several com-
pany boards, past and present, including DocuSign [NASDAQ: DOCU], Porch [NASDAQ: PRCH],
Homesnap (acquired by CoStar), Equity Lifestyles [NYSE:ELS] and ICON.
Mr. Freedman earned a B.S. from Boston University and a MBA from Harvard Business School.

Jessica Ginsberg
Director, LFM Capital
Jessica is a Director at LFM Capital and responsible for LFM’s business development activi-
ties, including overseeing the firm’s direct sourcing and outreach to intermediaries. She brings
to the Firm over 15 years of private equity, banking and investment management experience,
having served in a variety of roles that include business development, transaction diligence,
credit analysis and investor communications.
Prior to LFM, Jessica was a Portfolio Management Officer at Bank of America’s Middle Market
General Industrials group in Nashville. She previously served as a Vice President at Essex
Investment Management where she focused on small market-cap technology stocks and ear-
lier held roles as an Associate at Pamlico Capital (f/k/a Wachovia Capital Partners) and Willis
Stein & Partners, where she focused on middle market private equity investments.
Jessica received her BS, magna cum laude, in Finance and Accounting from Georgetown Uni-
versity.
Jessica grew up in St. Louis and enjoys spending time with her husband and three kids, Chase,
Julia and Turner. Outside of work, she loves exercising and staying current on Nashville’s ev-
er-changing restaurant scene.
Jessica Ginsberg
Director, LFM Capital
Jessica is a Director at LFM Capital and responsible for LFM’s business development activi-
ties, including overseeing the firm’s direct sourcing and outreach to intermediaries. She brings
to the Firm over 15 years of private equity, banking and investment management experience,
having served in a variety of roles that include business development, transaction diligence,
credit analysis and investor communications.
Prior to LFM, Jessica was a Portfolio Management Officer at Bank of America’s Middle Market
General Industrials group in Nashville. She previously served as a Vice President at Essex
Investment Management where she focused on small market-cap technology stocks and ear-
lier held roles as an Associate at Pamlico Capital (f/k/a Wachovia Capital Partners) and Willis
Stein & Partners, where she focused on middle market private equity investments.
Jessica received her BS, magna cum laude, in Finance and Accounting from Georgetown Uni-
versity.
Jessica grew up in St. Louis and enjoys spending time with her husband and three kids, Chase,
Julia and Turner. Outside of work, she loves exercising and staying current on Nashville’s ev-
er-changing restaurant scene.

NOTES
30
PANEL GROUP 2 | 11:00 – 11:50AM
STATE OF PE
LATAM
SEED FUNDS
INVESTING IN INCLUSIVE ECONOMIES
NOTES
30

PANEL GROUP 2 | 11:00 – 11:50AM
STATE OF PE
LATAM
SEED FUNDS
PANEL GROUP 2 | 11:00 – 11:50AM
STATE OF PE
LATAM
SEED FUNDS

32
The State of Private Equity | 11:00 – 11:50am | Main Stage
32
THE STATE OF PRIVATE EQUITY
11:00 – 11:50am | Main Stage
Panelists will discuss the latest trends in new transactions (including deal flow and
valuations)aswellaslastingimpactsfromCOVID-19,fundraisingandcapitaldeployment,
key sub-sector opportunities, and the outlook for the remainder of 2022 and beyond.
Major themes to cover include the rising importance of ESG and the longer-term outlook
for the industry.
PANEL CAPTAIN: Jessica Li
32
32
THE STATE OF PRIVATE EQUITY
11:00 – 11:50am | Main Stage
Panelists will discuss the latest trends in new transactions (including deal flow and
valuations)aswellaslastingimpactsfromCOVID-19,fundraisingandcapitaldeployment,
key sub-sector opportunities, and the outlook for the remainder of 2022 and beyond.
Major themes to cover include the rising importance of ESG and the longer-term outlook
for the industry.
PANEL CAPTAIN: Jessica Li

Will Boothby [MODERATOR]
Corporate Partner, Kirkland & Ellis
Will Boothby is a corporate partner in Kirkland & Ellis’s New York office, where he focuses on
mergers and acquisitions. He regularly represents private equity investors, private compa-
nies and public companies in a variety of strategic transactions, including leveraged buyouts,
carve-outs and minority investments. He also counsels clients with respect to general cor-
porate and governance matters and de-SPAC transactions. Will was recognized in the 2019–
2022 editions of IFLR1000 as a “Notable Practitioner” for Private Equity and M&A and named
as a “Rising Star” by in 2021.
Brendan Barrett
Director, Madison Dearborn
Brendan Barrett is a Director at Madison Dearborn Partners with the Financial & Transaction
Services team. Prior to MDP, he was an Investment Banking Analyst at Morgan Stanley. Bren-
dan serves on the Boards of Directors of BlueCat Networks, Intermedia.net, Inc. and Nava-
cord, and formerly served on the Board of Directors of EVO Payments International. Brendan
received an MBA from Harvard Business School and a Bachelor of Arts from the University
of Notre Dame.
Andrew Kaplan
Andrew Kaplan joined Bain Capital in 2009. He is a Partner of Bain Capital Private Equity, serv-
ing as a Managing Director and a senior leader of the Healthcare team. He has been a key con-
tributor in the acquisitions of Air Medical, Beacon Health, National Surgical Healthcare, Stada
Arzneimittel, Surgery Partners, US Renal Care, Value Options, InnovaCare and the acquisition
of assets from Healix, UPI, Bristol Myers Squibb and UnitedHealth to form the pharmaceutical
services firm QuVa Pharma. Andrew currently serves on the Board of Directors of Surgery
Partners, QuVa Pharma, US Renal Care and InnovaCare, and until recently Beacon Health
Options. He is also a Governing Trustee at the Dana-Farber Cancer Institute and serves as
Will Boothby [MODERATOR]
Corporate Partner, Kirkland & Ellis
Will Boothby is a corporate partner in Kirkland & Ellis’s New York office, where he focuses on
mergers and acquisitions. He regularly represents private equity investors, private compa-
nies and public companies in a variety of strategic transactions, including leveraged buyouts,
carve-outs and minority investments. He also counsels clients with respect to general cor-
porate and governance matters and de-SPAC transactions. Will was recognized in the 2019–
2022 editions of IFLR1000 as a “Notable Practitioner” for Private Equity and M&A and named
as a “Rising Star” by in 2021.
Brendan Barrett
Director, Madison Dearborn
Brendan Barrett is a Director at Madison Dearborn Partners with the Financial & Transaction
Services team. Prior to MDP, he was an Investment Banking Analyst at Morgan Stanley. Bren-
dan serves on the Boards of Directors of BlueCat Networks, Intermedia.net, Inc. and Nava-
cord, and formerly served on the Board of Directors of EVO Payments International. Brendan
received an MBA from Harvard Business School and a Bachelor of Arts from the University
of Notre Dame.
Andrew Kaplan
Andrew Kaplan joined Bain Capital in 2009. He is a Partner of Bain Capital Private Equity, serv-
ing as a Managing Director and a senior leader of the Healthcare team. He has been a key con-
tributor in the acquisitions of Air Medical, Beacon Health, National Surgical Healthcare, Stada
Arzneimittel, Surgery Partners, US Renal Care, Value Options, InnovaCare and the acquisition
of assets from Healix, UPI, Bristol Myers Squibb and UnitedHealth to form the pharmaceutical
services firm QuVa Pharma. Andrew currently serves on the Board of Directors of Surgery
Partners, QuVa Pharma, US Renal Care and InnovaCare, and until recently Beacon Health
Options. He is also a Governing Trustee at the Dana-Farber Cancer Institute and serves as

34
Vice Chair of the Boston Preparatory Academy’s Board of Trustees. Prior to Bain, Andrew was
an investment banker with Goldman Sachs. Andrew received an MBA from Harvard Business
School where he was a Baker Scholar. As an undergraduate, he attended The Wharton School
at the University of Pennsylvania, where he served as Class President for four years, and grad-
uated magna cum laude with a B.S. in Economics.
Chris Pike
Managing Partner, Advent
Chris Pike joined Advent in 1997 where he focuses on investments in the business & financial
services and healthcare sectors. Prior to Advent, Chris spent five years at Coopers & Lybrand
in the business assurance and financial advisory services groups, providing M&A advisory
services to clients in the financial, manufacturing and business services industries.
Chris received a B.A. in Economics and Spanish from Amherst College.
Robert Ruberton
Co-Head of Hybrid Value, Apollo
Robert Ruberton is Partner and Co-Head of Hybrid Value at Apollo Global Management, Inc.
Prior to joining in 2004, Rob was with Arsenal Capital Partners. Before that, he was an invest-
ment banker at Donaldson, Lufkin & Jenrette. Rob graduated cum laude from Harvard College
with an A.B. in economics and is a member of the board of trustees of the Peddie School and
of Montclair Kimberley Academy.
Lucy Stamell Dobrin
Principal, Providence Equity Partners
Lucy Stamell Dobrin is a principal in Providence Equity Partners’ New York office. She is cur-
rently a director of DoubleVerify and Smartly.io and was previously a director of EdgeConneX
and OEConnection. Prior to joining Providence in 2011, Ms. Dobrin worked as an analyst in the
financial sponsors investment banking group at Bank of America Merrill Lynch. Ms. Dobrin
received a Master of Arts and a Bachelor of Arts from the University of Pennsylvania.
34
Vice Chair of the Boston Preparatory Academy’s Board of Trustees. Prior to Bain, Andrew was
an investment banker with Goldman Sachs. Andrew received an MBA from Harvard Business
School where he was a Baker Scholar. As an undergraduate, he attended The Wharton School
at the University of Pennsylvania, where he served as Class President for four years, and grad-
uated magna cum laude with a B.S. in Economics.
Chris Pike
Managing Partner, Advent
Chris Pike joined Advent in 1997 where he focuses on investments in the business & financial
services and healthcare sectors. Prior to Advent, Chris spent five years at Coopers & Lybrand
in the business assurance and financial advisory services groups, providing M&A advisory
services to clients in the financial, manufacturing and business services industries.
Chris received a B.A. in Economics and Spanish from Amherst College.
Robert Ruberton
Co-Head of Hybrid Value, Apollo
Robert Ruberton is Partner and Co-Head of Hybrid Value at Apollo Global Management, Inc.
Prior to joining in 2004, Rob was with Arsenal Capital Partners. Before that, he was an invest-
ment banker at Donaldson, Lufkin & Jenrette. Rob graduated cum laude from Harvard College
with an A.B. in economics and is a member of the board of trustees of the Peddie School and
of Montclair Kimberley Academy.
Lucy Stamell Dobrin
Principal, Providence Equity Partners
Lucy Stamell Dobrin is a principal in Providence Equity Partners’ New York office. She is cur-
rently a director of DoubleVerify and Smartly.io and was previously a director of EdgeConneX
and OEConnection. Prior to joining Providence in 2011, Ms. Dobrin worked as an analyst in the
financial sponsors investment banking group at Bank of America Merrill Lynch. Ms. Dobrin
received a Master of Arts and a Bachelor of Arts from the University of Pennsylvania.

LATAM
11:00 – 11:50am | Ensemble E
The private equity market in Latin America has significantly developed over the past
decade. Global firms such as Advent International, HIG Capital, Softbank, and KKR have
devoted considerable resources to increase their presence in the region. Considered by
manyastheemergingmarkettoinvestin,GPsarefullyawarethatLatinAmericacarries
risks and multiple cultural, legal, and regulatory differences that often make it difficult
for international firms to operate with confidence. However, opportunities compensate
far beyond risks, and we are seeing a dramatic surge in interest for Latin America.
Almost three-quarters of private equity firms are planning to deploy capital in Latin
America over the next five years, fueled by attractive valuations and a growing appetite
for cross-border deal flow as the global economy recovers from the COVID-19 pandemic.
PANEL CAPTAIN: Juan Pablo Porras
LATAM
11:00 – 11:50am | Ensemble E
The private equity market in Latin America has significantly developed over the past
decade. Global firms such as Advent International, HIG Capital, Softbank, and KKR have
devoted considerable resources to increase their presence in the region. Considered by
manyastheemergingmarkettoinvestin,GPsarefullyawarethatLatinAmericacarries
risks and multiple cultural, legal, and regulatory differences that often make it difficult
for international firms to operate with confidence. However, opportunities compensate
far beyond risks, and we are seeing a dramatic surge in interest for Latin America.
Almost three-quarters of private equity firms are planning to deploy capital in Latin
America over the next five years, fueled by attractive valuations and a growing appetite
for cross-border deal flow as the global economy recovers from the COVID-19 pandemic.
PANEL CAPTAIN: Juan Pablo Porras

36
LatAm | 11:00 – 11:50am | Ensemble E
Sergio Urias [MODERATOR]
Partner, Covington and Burling
Sergio Urias is co-chair of Covington and Burling LLP and a member of the Corporate Prac-
tice Group. Sergio represents leading private equity funds and their portfolio companies in a
wide range of corporate transactions, including domestic and cross-border (primarily in Latin
America) mergers and acquisitions, recapitalizations, leveraged financings, restructurings,
reorganizations, growth equity investments, and other corporate transactional matters. In ad-
dition, he negotiates, structures, and executes corporate transactions on behalf of strategic
buyers and sellers.
Sergio has extensive industry experience representing clients across a broad spectrum of
sectors, including technology, media, telecommunications, consumer products, energy, min-
ing, healthcare, life sciences, food and beverage, software, manufacturing, financial services,
agriculture, aerospace, defense, and hospitality. As a result, he can anticipate and address
industry-unique issues that often arise in the transaction process and structure the transac-
tions efficiently.
Sergio also has extensive experience advising clients on complex inbound and outbound pri-
vate equity and M&A transactions in Latin America and is recognized by The Legal 500 among
its Private Practice Power list: U.S.-Mexico (2017).
Martín Escobari
Co-President & Head of Latin America, General Atlantic
Martín Escobari is Co-President, Managing Director and Head of General Atlantic’s business
in Latin America. Martín is also Chairman of the firm’s Investment Committee and serves on
the Management and Portfolio Committees.
Before joining General Atlantic in 2012, Martín was a Managing Director at Advent Internation-
al, where he focused on the financial services sector. Prior to that, he was Co-Founder and
CFO of Submarino.com, a leading Brazilian online retailer that went public on the Bovespa and
was sold to Lojas Americanas in 2006. Martín started his career as a management consultant
at The Boston Consulting Group.
36
Sergio Urias [MODERATOR]
Partner, Covington and Burling
Sergio Urias is co-chair of Covington and Burling LLP and a member of the Corporate Prac-
tice Group. Sergio represents leading private equity funds and their portfolio companies in a
wide range of corporate transactions, including domestic and cross-border (primarily in Latin
America) mergers and acquisitions, recapitalizations, leveraged financings, restructurings,
reorganizations, growth equity investments, and other corporate transactional matters. In ad-
dition, he negotiates, structures, and executes corporate transactions on behalf of strategic
buyers and sellers.
Sergio has extensive industry experience representing clients across a broad spectrum of
sectors, including technology, media, telecommunications, consumer products, energy, min-
ing, healthcare, life sciences, food and beverage, software, manufacturing, financial services,
agriculture, aerospace, defense, and hospitality. As a result, he can anticipate and address
industry-unique issues that often arise in the transaction process and structure the transac-
tions efficiently.
Sergio also has extensive experience advising clients on complex inbound and outbound pri-
vate equity and M&A transactions in Latin America and is recognized by The Legal 500 among
its Private Practice Power list: U.S.-Mexico (2017).
Martín Escobari
Co-President & Head of Latin America, General Atlantic
Martín Escobari is Co-President, Managing Director and Head of General Atlantic’s business
in Latin America. Martín is also Chairman of the firm’s Investment Committee and serves on
the Management and Portfolio Committees.
Before joining General Atlantic in 2012, Martín was a Managing Director at Advent Internation-
al, where he focused on the financial services sector. Prior to that, he was Co-Founder and
CFO of Submarino.com, a leading Brazilian online retailer that went public on the Bovespa and
was sold to Lojas Americanas in 2006. Martín started his career as a management consultant
at The Boston Consulting Group.

Martín currently sits on the boards of General Atlantic portfolio companies Arco, dLocal, Gru-
po Axo, Incode, Pague Menos, Sanfer and XP Investimentos. He also serves on the boards of
Lincoln Center and Primeira Chance, as an advisory group member to the Rockefeller Center
for Latin American Studies at Harvard, and as a mentor to young entrepreneurs with Endeavor.
Martín received a B.A. in Economics from Harvard College and an MBA from Harvard Busi-
ness School.
Farah Khan
Partner, L Catterton
Ms. Khan is a Partner at L Catterton focused on Latin America. She started her career at the
firm focused on North American growth equity and buyout investments. Prior to joining L
Catterton, Ms. Khan was a Vice President at Sandler Capital Management where she focused
on growth equity, leveraged buyouts and financings of middle market companies. Prior to
Sandler, Ms. Khan worked at Apax Partners, a global private equity firm where she focused
on growth capital and leveraged buyouts in the retail and consumer product sectors. Prior to
Apax, she worked in the Investment Banking Division of Goldman Sachs, where she focused
on corporate finance and M&A coverage of retail, media and technology companies based in
both New York and Menlo Park. Ms. Khan is a Phi Beta Kappa and summa cum laude graduate
of Mount Holyoke College with a B.A. degree in Economics and Mathematics. She received an
MBAfrom the Stanford University Graduate School of Business.
Fernando Marques Oliveira
Managing Director, H.I.G. Capital
Marques Oliveira is a Managing Director at H.I.G. Capital and heads up H.I.G. Brasil and H.I.G.
Latin America. Mr. Marques Oliveira has more than 18 years of experience in the Latin Amer-
ican private equity market and has led or co-led more than 25 successful investments in the
region in various sectors such as Consumer, Manufacturing, Services,
Healthcare, Media/Advertising, Software, Food & Beverage, Mining, Real Estate, Education,
Pulp & Paper, Internet and Financial Services.
Martín currently sits on the boards of General Atlantic portfolio companies Arco, dLocal, Gru-
po Axo, Incode, Pague Menos, Sanfer and XP Investimentos. He also serves on the boards of
Lincoln Center and Primeira Chance, as an advisory group member to the Rockefeller Center
for Latin American Studies at Harvard, and as a mentor to young entrepreneurs with Endeavor.
Martín received a B.A. in Economics from Harvard College and an MBA from Harvard Busi-
ness School.
Farah Khan
Partner, L Catterton
Ms. Khan is a Partner at L Catterton focused on Latin America. She started her career at the
firm focused on North American growth equity and buyout investments. Prior to joining L
Catterton, Ms. Khan was a Vice President at Sandler Capital Management where she focused
on growth equity, leveraged buyouts and financings of middle market companies. Prior to
Sandler, Ms. Khan worked at Apax Partners, a global private equity firm where she focused
on growth capital and leveraged buyouts in the retail and consumer product sectors. Prior to
Apax, she worked in the Investment Banking Division of Goldman Sachs, where she focused
on corporate finance and M&A coverage of retail, media and technology companies based in
both New York and Menlo Park. Ms. Khan is a Phi Beta Kappa and summa cum laude graduate
of Mount Holyoke College with a B.A. degree in Economics and Mathematics. She received an
MBAfrom the Stanford University Graduate School of Business.
Fernando Marques Oliveira
Managing Director, H.I.G. Capital
Marques Oliveira is a Managing Director at H.I.G. Capital and heads up H.I.G. Brasil and H.I.G.
Latin America. Mr. Marques Oliveira has more than 18 years of experience in the Latin Amer-
ican private equity market and has led or co-led more than 25 successful investments in the
region in various sectors such as Consumer, Manufacturing, Services,
Healthcare, Media/Advertising, Software, Food & Beverage, Mining, Real Estate, Education,
Pulp & Paper, Internet and Financial Services.

VCPE Conference 2022 Conference Book

VCPE Conference 2022 Conference Book

Recommended

Recommended

More Related Content

Similar to VCPE Conference 2022 Conference Book

Similar to VCPE Conference 2022 Conference Book (20)

Recently uploaded

Recently uploaded (20)

VCPE Conference 2022 Conference Book